Table 1.
Overall (n = 15) | |
---|---|
Age | |
Median [Min, Max] | 66.0 [37.0, 82.0] |
Sex | |
Male | 12 (80.0%) |
Female | 3 (20.0%) |
BMI | |
Mean (SD) | 25.2 (6.61) |
Median [Min, Max] | 23.3 [14.8, 40.2] |
Primary tumor site | |
Nasopharynx | 3 (20.0%) |
Oropharynx | 8 (53.3%) |
Hypopharynx | 1 (6.7%) |
Larynx | 3 (20.0%) |
Histology | |
Adeno | 1 (6.7%) |
Squamous | 14 (93.3%) |
HPV status | |
Negative | 7 (46.7%) |
Positive | 5 (33.3%) |
Not reported | 3 (20.0%) |
Treatment | |
Chemoradiotherapy (CRT) | 9 (60.0%) |
Radiotherapy & Antibody therapy | 4 (26.7%) |
Radiotherapy (RT) | 2 (13.3%) |
BMI body mass index, HPV human papilloma virus